Exploring the facilitators and barriers to using an online infertility risk prediction tool (FoRECAsT) for young women with breast cancer: a qualitative study protocol.
INTRODUCTION
As cancer treatments may impact on fertility, a high priority for young patients with breast cancer is access to evidence-based, personalised information for them and their healthcare providers to guide treatment and fertility-related decisions prior to cancer treatment. Current tools to predict fertility outcomes after breast cancer treatments are imprecise and do not offer individualised prediction. To address the gap, we are developing a novel personalised infertility risk prediction tool (FoRECAsT) for premenopausal patients with breast cancer that considers current reproductive status, planned chemotherapy and adjuvant endocrine therapy to determine likely post-treatment infertility. The aim of this study is to explore the feasibility of implementing this FoRECAsT tool into clinical practice by exploring the barriers and facilitators of its use among patients and healthcare providers.


METHODS AND ANALYSIS
A cross-sectional exploratory study is being conducted using semistructured in-depth telephone interviews with 15-20 participants each from the following groups: (1) premenopausal patients with breast cancer younger than 40, diagnosed within last 5 years, (2) breast surgeons, (3) breast medical oncologists, (4) breast care nurses (5) fertility specialists and (6) fertility preservation nurses. Patients with breast cancer are being recruited from the joint Breast Service of three affiliated institutions of Victorian Comprehensive Cancer Centre in Melbourne, Australia-Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Royal Women's Hospital, and clinicians are being recruited from across Australia. Interviews are being audio recorded, transcribed verbatim and imported into qualitative data analysis software to facilitate data management and analyses.


ETHICS AND DISSEMINATION
The study protocol has been approved by Melbourne Health Human Research Ethics Committee, Australia (HREC number: 2017.163). Confidentiality and privacy are maintained at every stage of the study. Findings will be disseminated through peer-reviewed scholarly and scientific journals, national and international conference presentations, social media, broadcast media, print media, internet and various community/stakeholder engagement activities.
['Edib|Zobaida|Z|0000-0001-7381-7351', 'Jayasinghe|Yasmin|Y|', 'Hickey|Martha|M|', 'Stafford|Lesley|L|', 'Anderson|Richard A|RA|', 'Su|H Irene|HI|', 'Stern|Kate|K|', 'Saunders|Christobel|C|', 'Anazodo|Antoinette|A|', 'Macheras-Magias|Mary|M|', 'Chang|Shanton|S|', 'Pang|Patrick|P|', 'Agresta|Franca|F|', 'Chin-Lenn|Laura|L|', 'Cui|Wanyuan|W|', 'Pratt|Sarah|S|', 'Gorelik|Alex|A|', 'Peate|Michelle|M|']
D000293:Adolescent D000328:Adult D001315:Australia D001943:Breast Neoplasms D003430:Cross-Sectional Studies D005240:Feasibility Studies D005260:Female D006297:Health Services Accessibility D006801:Humans D007246:Infertility D020407:Internet D007407:Interviews as Topic D036301:Qualitative Research D012107:Research Design D018570:Risk Assessment D055815:Young Adult
infertility risk prediction breast cancer premenopausal